FluoroPharma Medical, Inc. Financial Ratios — FPMI Stock

Profitability (USD)

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Return on Common Equity (%)	- -	- -	- -	- -	- -	-184.35	- -	- -	- -	- -
Return on Assets (%)	- -	-97.32	-339.63	-1,652.62	-178.18	-155.69	-317.76	-301.95	-381.44	-349.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	94.75	89.87	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-220.77	-7.78	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-221.6	-8.44	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	0.66	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-65.56	-10.02	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-65.56	-10.08	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-65.56	-10.08	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	23.06	4.01	23.02	11.97	15.36	20.34
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	-176.95	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Total Debt	- -	- -	- -	1	- -	- -	- -	2	4	6
ST Debt	- -	- -	- -	1	- -	- -	- -	2	4	6
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.12	-2.07	-2.76	-0.63	- -	- -	- -	-0.41	-1.39	-2.7
Net Debt/EBITDA	-0.1	-2.06	-2.76	-0.62	1.01	0.32	0.26	-0.37	-1.29	-2.69
Total Debt/EBIT	-0.12	-1.91	-2.56	-0.6	- -	- -	- -	-0.41	-1.37	-2.64
Net Debt/EBIT	-0.1	-1.9	-2.56	-0.59	1	0.31	0.26	-0.36	-1.27	-2.63
EBITDA to Interest Expense	-102.55	-4.9	-5.33	-16	-28.55	- -	-84.47	-49.23	-3.6	-1.71
EBITDA-CapEx/Interest Expense	-104.85	-4.9	-5.33	-16.09	-30.19	- -	-84.57	-52.65	-3.6	-1.71
EBIT to Interest Expense	-102.93	-5.32	-5.75	-16.77	-28.91	- -	-84.95	-49.64	-3.65	-1.75
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Common Equity/Total Assets	-48.08	-361.37	-1,814.47	-1,697.17	89.22	85.27	-55.57	-585.63	-937.98	-3,042.38
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	30.83	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	20.89	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-240.94	-91.83	-87.19	-28.09	- -	- -	- -	-44.27	-55.33	-57.22
Total Debt/Capital (%)	170.95	-1,123.74	-680.82	-39.06	- -	- -	- -	-79.43	-123.88	-133.75
Total Debt/Total Assets (%)	115.83	331.84	1,582.09	476.75	- -	- -	- -	258.89	518.66	1,739.92
Net Debt to Equity	-189.15	-91.39	-87.03	-27.5	-103.13	-94.63	108.21	-39.01	-51.63	-56.98
Net Debt/Capital (%)	212.18	-1,061.65	-671.06	-37.92	3,293.13	-1,763.73	51.97	-63.97	-106.76	-132.43
EBITDA	- -	- -	- -	-1	-3	-4	-4	-5	-3	-2
EBITDA-CapEx	- -	- -	- -	-1	-3	-4	-4	-5	-3	-2
Operating Income (Loss)	- -	- -	- -	-1	-3	-4	-4	-5	-3	-2

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Cash Ratio	0.2	- -	- -	0.01	8.58	5.54	0.6	0.05	0.03	- -
Current Ratio	0.65	0.12	- -	0.01	8.72	5.87	0.62	0.08	0.06	- -
Quick Ratio	0.36	- -	- -	0.01	8.58	5.54	0.6	0.05	0.03	- -
CFO/Avg Current Liab	- -	-0.08	-0.35	-0.46	-1.89	-10.65	-2.08	-0.77	-0.37	-0.09
Common Equity/Total Assets	-48.08	-361.37	-1,814.47	-1,697.17	89.22	85.27	-55.57	-585.63	-937.98	-3,042.38
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	30.83	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	20.89	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-240.94	-91.83	-87.19	-28.09	- -	- -	- -	-44.27	-55.33	-57.22
Total Debt/Capital (%)	170.95	-1,123.74	-680.82	-39.06	- -	- -	- -	-79.43	-123.88	-133.75
Total Debt/Total Assets (%)	115.83	331.84	1,582.09	476.75	- -	- -	- -	258.89	518.66	1,739.92
CFO/Total Liabilities	-175.77	-7.92	-31.1	-23.41	-599.36	-1,393.04	-112.1	-59.13	-30.77	-8.37
CFO/CapEx	-12.51	- -	- -	-100.01	-12.26	-80.16	-622.07	-9.32	-399.89	-680.68
Altman's Z-Score	-30.99	-5.54	-104.7	-301.16	17.44	27.13	-23.26	-136.37	-126.21	-1,251.01

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Accounts Receivable Turnover	- -	60.52	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	6.03	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	2.37	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	153.97	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	3.08	-2.98	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	118.51	-122.28	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	41.49	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-147.94	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Market Capitalization	- -	- -	- -	- -	16	20	16	12	10	4
- Cash & Cash Equivalents	- -	- -	- -	- -	3	1	1	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	1	- -	- -	- -	2	4	6
Enterprise Value	- -	- -	- -	1	12	18	15	14	14	10
Total Capital	- -	- -	- -	-1	3	1	-1	-3	-4	-4
Total Debt/Capital (%)	170.95	-1,123.74	-680.82	-39.06	- -	- -	- -	-79.43	-123.88	-133.75
Total Debt / EV	1.27	1	1	1.02	- -	- -	- -	0.16	0.31	0.61
EV/Sales	0.22	0.16	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.15
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.07
Diluted Market Cap	- -	- -	- -	- -	12	18	16	11	9	- -
Diluted Enterprise Value	- -	- -	- -	1	9	17	14	13	13	6
EV per Share	- -	- -	- -	0.05	0.55	0.76	0.57	0.46	0.42	0.28
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	-1	-3	-4	-4	-5	-3	-2
TTM Operating Income	- -	- -	- -	-1	-3	-4	-4	-5	-3	-2
TTM Cash Flow to Firm	- -	- -	- -	- -	-2	-3	-3	-3	-2	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	-2	-3	-3	-3	-2	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016

Price/Free Cash Flow	- -	- -	- -	- -	-5.93	-5.66	-4.69	-3.86	-3.37	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	1	12	18	15	14	14	10
Low Price	- -	- -	- -	- -	0.56	0.51	0.48	0.33	0.14	0.1
EV/Sales	0.22	0.16	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	-6.11	-4.42	-2.34	-3.76	-2.79	- -
Price/Earnings High	- -	- -	- -	- -	-9	-6.44	-3.18	-5.62	-4.42	- -
Price/Earnings Low	- -	- -	- -	- -	-2.34	-2.76	-1.59	-2	-1.13	- -
Price/Book Value	- -	- -	- -	- -	4.94	14.32	-15.43	-2.43	-1.26	-0.37
Price/Book Value Average	- -	- -	- -	- -	10.29	14.45	-16.89	-3.74	-1.45	-0.75
Price/Book Value High	- -	- -	- -	- -	15.16	21.04	-22.91	-5.59	-2.3	-1.24
Price/Book Value Low	- -	- -	- -	- -	3.95	9.02	-11.48	-1.99	-0.59	-0.33
Price/Tangible Book Value	- -	- -	- -	- -	5.03	14.92	-14.75	-2.26	-1.21	-0.36
Price/Tangible Book Value Average	- -	- -	- -	- -	10.49	15.06	-16.14	-3.48	-1.4	-0.73
Price/Tangible Book Value High	- -	- -	- -	- -	15.46	21.92	-21.9	-5.2	-2.21	-1.2
Price/Tangible Book Value Low	- -	- -	- -	- -	4.03	9.4	-10.97	-1.85	-0.57	-0.33
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	-5.44	-5.59	-4.68	-3.45	-3.37	- -
Price/Cash Flow Average	- -	- -	- -	- -	-11.35	-5.64	-5.12	-5.31	-3.9	- -
Price/Cash Flow High	- -	- -	- -	- -	-16.72	-8.21	-6.95	-7.93	-6.17	- -
Price/Cash Flow Low	- -	- -	- -	- -	-4.36	-3.52	-3.48	-2.82	-1.58	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	-12.36	-5.71	-5.13	-5.95	-3.91	- -
Price/Free Cash Flow High	- -	- -	- -	- -	-18.21	-8.32	-6.96	-8.89	-6.19	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	-4.74	-3.56	-3.49	-3.16	-1.59	- -
EV/Sales Average	0.22	0.16	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	0.22	0.16	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	0.22	0.16	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.1	-2.06	-2.76	-0.62	-9.07	-4.51	-3.88	-3.87	-4.93	-6.24
EV/EBITDA High	-0.1	-2.06	-2.76	-0.62	-13.84	-6.7	-5.36	-5.61	-7.06	-8.53
EV/EBITDA Low	-0.1	-2.06	-2.76	-0.62	-2.86	-2.69	-2.56	-2.23	-2.77	-4.27
EV/EBIT Average	-0.1	-1.9	-2.56	-0.59	-8.95	-4.48	-3.86	-3.84	-4.86	-6.11
EV/EBIT High	-0.1	-1.9	-2.56	-0.59	-13.66	-6.66	-5.33	-5.56	-6.96	-8.36
EV/EBIT Low	-0.1	-1.9	-2.56	-0.59	-2.82	-2.68	-2.54	-2.21	-2.73	-4.18
Last Price	- -	- -	- -	- -	0.7	0.81	0.64	0.4	0.3	0.11
High Price	- -	- -	- -	- -	2.15	1.19	0.95	0.92	0.55	0.37
Enterprise Value Average	- -	- -	- -	1	29	19	17	20	15	13
Enterprise Value High	- -	- -	- -	1	45	28	23	29	22	18
Enterprise Value Low	- -	- -	- -	1	9	11	11	11	9	9

Shares Outstanding	11	11	11	11	22	24	26	29	33	34
Diluted Weighted Avg Shares	11	11	11	13	18	23	24	29	30	- -
Basic Weighted Avg Shares	11	11	11	13	18	23	24	29	30	- -
Revenue per Share	0.01	0.02	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.02	- -	- -	-0.07	-0.18	-0.18	-0.18	-0.18	-0.1	- -
Operating Income per Share	-0.02	- -	- -	-0.07	-0.18	-0.18	-0.18	-0.18	-0.11	- -
Basic EPS, GAAP	-0.01	- -	- -	-0.08	-0.24	-0.18	-0.3	-0.16	-0.12	- -
Basic EPS from Cont Ops	-0.01	- -	- -	-0.08	-0.18	-0.18	-0.23	-0.14	-0.11	- -
Diluted EPS, GAAP	-0.01	- -	- -	-0.08	-0.24	-0.18	-0.3	-0.16	-0.12	- -
Diluted EPS from Cont Ops	-0.01	- -	- -	-0.08	-0.18	-0.18	-0.23	-0.14	-0.11	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.01	- -	- -	-0.04	-0.13	-0.14	-0.14	-0.12	-0.09	- -
Free Cash Flow per Basic Share	-0.01	- -	- -	-0.04	-0.14	-0.15	-0.14	-0.13	-0.09	- -
Cash & Equivalents per Share	- -	- -	- -	- -	0.15	0.05	0.07	0.01	0.01	- -
Book Value per Share	- -	- -	- -	-0.17	0.14	0.06	-0.04	-0.16	-0.24	-0.3
Tangible Book Value per Share	- -	- -	- -	-0.18	0.14	0.05	-0.04	-0.18	-0.25	-0.31

FluoroPharma Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)